Ampio Pharmaceuticals Inc (PK) News - AMPE

Proxy Statement (definitive) (def 14a)

Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Current Report Filing (8-k)

0001411906false--12-3100014119062023-05-242023-05-24UNITED STATESSECURITIES AND EXCHANGE...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Quarterly Report (10-q)

0001411906--12-312023Q1false1510287715102877237873000P125M00014119062022-11-092022-11-090001411906srt:Cumulative...

Amended Annual Report (10-k/a)

0001411906--12-312022FYfalse00014119062022-06-3000014119062023-04-2100014119062022-01-012022-12-31xbrli:sharesis...

Current Report Filing (8-k)

0001411906false00014119062023-04-182023-04-18UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT...

Annual Report (10-k)

0000014119062022FYfalse15102877151721110http://fasb.org/us-gaap/2022#GainLossOnDerivativeInstrumentsNetPretax000...

Current Report Filing (8-k)

0001411906false00014119062023-03-102023-03-10UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Current Report Filing (8-k)

0001411906false00014119062022-12-272022-12-27UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT...

Current Report Filing (8-k)

0001411906false00014119062022-11-172022-11-17UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT...

Quarterly Report (10-q)

0001411906--12-312022Q3false1508579215155026P125M0001411906us-gaap:RetainedEarningsMemberampe:AtMarketEquityOffe...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ampio Pharmaceuticals Inc (PK) (AMPE)

Professional-Grade Tools, for Individual Investors.

AMPE News

Proxy Statement (definitive) (def 14a)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Quarterly Report (10-q)

Amended Annual Report (10-k/a)

Current Report Filing (8-k)

Annual Report (10-k)

Current Report Filing (8-k)

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

AMPE Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ampio Pharmaceuticals Inc (PK) (AMPE) News

Ampio Pharmaceuticals Inc (PK) (AMPE)

Professional-Grade Tools, for Individual Investors.

AMPE News

Proxy Statement (definitive) (def 14a)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Quarterly Report (10-q)

Amended Annual Report (10-k/a)

Current Report Filing (8-k)

Annual Report (10-k)

Current Report Filing (8-k)

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

AMPE Discussion

Your Recent History